Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 15;39(5):91.
doi: 10.1007/s12032-022-01693-0.

The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications

Seyed Hossein Shahcheraghi  1   2 , Fateme Salemi  3 , Waqas Alam  4 , Henry Ashworth  5 , Luciano Saso  6 , Haroon Khan  7 , Marzieh Lotfi  8   9
Affiliations
Review

The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications

Seyed Hossein Shahcheraghi et al. Med Oncol. .

Abstract

Glioblastoma multiforme (GBM) grade IV glioma is the most frequent and deadly intracranial cancer. This tumor is determined by unrestrained progression, uncontroled angiogenesis, high infiltration and weak response to treatment, which is chiefly because of abnormal signaling pathways in the tumor. A member related to the Cap 'n' collar family of keypart-leucine zipper transcription agents-the transcription factor NF-E2-related factor 2 (Nrf2)-regulates adaptive protection answers by organized upregulation of many genes that produce the cytoprotective factors. In reply to cellular pressures types such as stresses, Nrf2 escapes Kelch-like ECH-related protein 1 (Keap1)-facilitated suppression, moves from the cytoplasm towards the nucleus and performs upregulation of gene expression of antioxidant responsive element (ARE). Nrf2 function is related tocontrolling many types of diseases in the human specially GBM tumor.Thus, we will review the epigeneticalregulatory actions on the Nrf2/Keap1 signaling pathway and potential therapeutic options in GBM by aiming the stimulation of Nrf2.

Keywords: Glioblastoma multiforme; Kelch-like ECH-related protein 1; NF-E2-related factor 2; Therapeutic options.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wirsching H-G, Galanis E, Weller M. Glioblastoma. Handb Clin Neurol. 2016;134:381–97. - PubMed - DOI
    1. Ahmed S, Hasan MM, Aschner M, Mirzaei H, Alam W, Shah SMM, et al. Therapeutic potential of marine peptides in glioblastoma: Mechanistic insights. Cel Signal. 2021;87:110142. - DOI
    1. Kourti M, Jiang WG, Cai J. Aspects of carbon monoxide in form of CO-releasing molecules used in cancer treatment: more light on the way. Oxid Med Cell Longev. 2017;2017:1–12. - DOI
    1. Nakada M, Kita D, Watanabe T, Hayashi Y, Teng L, Pyko IV, et al. Aberrant signaling pathways in glioma. Cancers. 2011;3(3):3242–78. - PubMed - PMC - DOI
    1. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007;21(21):2683–710. - PubMed - DOI

MeSH terms

LinkOut - more resources